Participated · Seed · Jun 2026

Paypercut provides a full payments stack for online merchants across Central and Eastern Europe via a single integration, combining card payments, local payment methods, and multiple Buy Now Pay Later providers. Since its EUR 2M pre-seed in July 2025 the company has expanded to serve over 200 merchants across eight CEE markets and evolved from a BNPL aggregator into a full payments platform. Key product features include multi-currency settlement, onboarding fully online in days, payment links and QR payments, and an Express Checkout launching to enable one-tap Apple Pay and Google Pay flows. Paypercut operates through licensed and regulated partners across the EEA and has submitted its own EMI application with the Central Bank of Ireland, expecting authorisation in Q4 2026. The company is also developing stablecoin-based rails for high-volume non-euro corridors (starting with EUR-to-PLN and EUR-to-RON) and has a roadmap extending into treasury, FX, payouts, and embedded financial services.

Participated · Seed · May 2026

Boundary Labs designs and operates the Boundary Protocol and USBD, a stablecoin built for continuous on-chain verifiability of reserves and performance for institutional counterparties. The protocol emphasizes institutional-only onboarding via a dedicated dApp with rigorous KYC/KYB workflows and aims to support use cases such as treasury management, regulated wrappers, and on-chain collateral. Boundary completed a security audit by Cyfrin and demonstrated a proof-of-concept for its protocol's self-funding capability through derisked decentralized market participation. The company has set an initial operational target of $100M in Total Value Locked (TVL) in 2026 and plans a Private Placement Campaign to onboard initial institutional partners. Boundary raised $2M in a pre-seed round led by Galaxy Ventures with participation from BlackWood, FirstBlock Capital, and other institutional partners and angels. The firm is based in New York City and is mandated by the Boundary Foundation and Boundary OpCo to lead the project's design, development, and commercial representation.

Participated · Series A · Feb 2026

Founded in 2022, Sidekick offers a modern wealth-management platform aimed at professionals whose financial needs have outgrown entry-level investing apps. The service combines low-cost public-market investing, customised portfolios, private-market opportunities and Lombard loans secured against customers’ portfolios—products historically reserved for private banks. Sidekick’s managed strategies include offerings such as the All Weather portfolio, while its Multi Shield Savings product spreads cash across multiple partner banks to maximise FSCS protection. The company claims to manage more than £145 million in customer assets, underscoring demand for greater transparency and control among affluent professionals. Fees are presented transparently and clients receive guidance from in-house financial experts. With fresh capital, Sidekick plans to scale its product suite, grow headcount and expand operations in Cardiff while continuing to build out its technology platform.

Participated · Seed · Dec 2025

Cellens builds BioFeel, a mechanobiology and machine-learning platform that detects bladder cancer from urine samples by physically “feeling” cellular stiffness with atomic-force microscopy and converting those measurements into biophysical biomarkers. By relying on physics rather than solely on molecular markers, the test addresses tumor heterogeneity that limits current urine assays and eliminates many unnecessary, invasive cystoscopies. In a prospective study of nearly 100 patient samples, BioFeel correctly identified every recurrence case and markedly outperformed FDA-cleared molecular tests that typically reach only 60–65 % sensitivity. The technology originates from research at Tufts University and has been validated with Dartmouth Medical Center and the University of Washington Medical Center. With an estimated 83,190 new U.S. bladder-cancer cases in 2024 and 800,000 patients under surveillance, Cellens targets a large, costly monitoring market. The company plans to use its new capital to advance clinical validation, pursue regulatory clearance and scale commercialization. Cellens has raised $6.5 million in seed funding to date; no revenue metrics have been disclosed.

Participated · Seed · Oct 2025

London-based Rightcharge has developed a software platform that connects drivers’ home energy accounts, public charge cards and fleet vehicles into a single billing system, enabling automated, tax-compliant reimbursement for electric-vehicle charging. By crediting payments directly to electricity bills, the service maintains accuracy as tariffs change, reduces fraud through AI-driven anomaly detection, and produces HMRC-compliant audit trails. A companion public charge card gives access to more than 70 % of UK public chargers, while all costs flow into one consolidated monthly invoice. Early adopters include The Automobile Association (AA) and fleets across construction, healthcare and government sectors. Customers report up to 90 % reductions in charging costs, roughly 30 % lower carbon emissions and significantly reduced administrative work. The company plans to use new capital to expand across Europe, supported by a partnership with Octopus Electroverse. Rightcharge recently closed a seed funding round to finance these growth initiatives.